Stephen Nash
Impact in
- Oncology top 10%
- Vascular Tumors and Angiosarcomas
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- HIV/AIDS Research and Interventions 10
- Infection Control in Healthcare 4
- Epidemiology 13
- HIV, Drug Use, Sexual Risk 6
- Cytomegalovirus and herpesvirus research 4
- Co-authors
- Beatrice Seddon (2 shared papers)Christian Rothermundt (2 shared papers)Fiona Cowie (2 shared papers)Sandra J. Strauss (2 shared papers)Michael Leahy (2 shared papers)Jeremy Whelan (2 shared papers)Sharon Forsyth (2 shared papers)Penella J. Woll (2 shared papers)
- Journals
- Emergency Medicine Journal (3 papers)Vaccine (3 papers)PLoS ONE (3 papers)Pediatric Allergy and Immunology (2 papers)The Journal of Infectious Diseases (2 papers)
- Partner nations
- United KingdomUnited StatesUganda
In The Last Decade
Stephen Nash
64 papers receiving 1.6k citations
Stephen Nash's Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 453
- Pulmonary and Respiratory Medicine 458
- Infectious Diseases 259
- Obstetrics and Gynecology 89
- Developmental Biology 23
Countries citing papers authored by Stephen Nash
This map shows the geographic impact of Stephen Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Nash more than expected).
Fields of papers citing papers by Stephen Nash
This network shows the impact of papers produced by Stephen Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Nash. The network helps show where Stephen Nash may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Nash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial Hit paper breakdown → | 2017 | 340 |
| 2 | 2014 | 213 | |
| 3 | 2002 | 108 | |
| 4 | 2021 | 96 | |
| 5 | 2017 | 88 | |
| 6 | 2017 | 83 | |
| 7 | 2015 | 57 | |
| 8 | 2016 | 55 | |
| 9 | 2016 | 47 | |
| 10 | 2015 | 44 | |
| 11 | 2016 | 39 | |
| 12 | 2017 | 37 | |
| 13 | 2012 | 28 | |
| 14 | 2018 | 24 | |
| 15 | 1996 | 23 | |
| 16 | 1998 | 23 | |
| 17 | 2017 | 22 | |
| 18 | 2018 | 22 | |
| 19 | 2017 | 21 | |
| 20 | 2007 | 18 |
About Stephen Nash
Stephen Nash is a scholar working on Infectious Diseases, Epidemiology, Oncology, Public Health, Environmental and Occupational Health and General Health Professions, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (10 papers), HIV, Drug Use, Sexual Risk (6 papers), Global Maternal and Child Health (6 papers), Asthma and respiratory diseases (4 papers), HIV Research and Treatment (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Infection Control in Healthcare (4 papers). The work is most often cited by research in Oncology (453 citations), Pulmonary and Respiratory Medicine (458 citations), Infectious Diseases (259 citations), Obstetrics and Gynecology (89 citations) and Developmental Biology (23 citations). Stephen Nash has collaborated with scholars based in United Kingdom, United States and Uganda. Frequent co-authors include Beatrice Seddon, Christian Rothermundt, Fiona Cowie, Sandra J. Strauss, Michael Leahy, Jeremy Whelan, Sharon Forsyth, Penella J. Woll, Hakim‐Moulay Dehbi and Nasim Ali. Their work appears in journals such as Emergency Medicine Journal, Vaccine, PLoS ONE, Pediatric Allergy and Immunology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.